University of Cambridge > > euroscicon > The 2014 Alzheimer's Disease Congress

The 2014 Alzheimer's Disease Congress

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Speaker to be confirmed.

This three day event will discuss aspects of Alzheimer’s Disease development and treatment in an informal academic setting. This year there are three main topics for discussion:

  • Biomarker Discovery and Assay Development
  • Prevention Strategies and Vaccine Development
  • Drug Discovery and Development

With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding Alzheimer’s Disease.

This event has CPD accreditation and an open oral and poster session. Abstracts can be submitted on any subject related to Alzheimer’s Disease

The deadline for abstract submissions for oral presentation is March 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at

Program Outline

Day 1: Biomarker Discovery and Assay Development Currently, there are many biomarkers for diagnosis of Alzheimer’s disease. However most of them do not provide consistent results. This session will discuss current research aimed at obtaining reliable biomarkers which could be used to diagnose Alzheimer’s disease at very early stage and also to provide objective and reliable measures of disease progress.

Day 2: Prevention Strategies and Vaccine Development This session will discuss current research into Alzheimer’s Disease prevention including vaccine development. There will be plenty of opportunity for discussion and debate.

Day 3: Drug Discovery and Development There are currently no treatments that will stop or reverse the progress of Alzheimer’s disease. With an aging population and increasing number of people with Alzheimer’s, the need to develop ways to halt and treat the disease have become paramount. This session will discuss current research into Alzheimer’s drug discovery and development including analysis of current clinical trials

This talk is part of the euroscicon series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity